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INTRODUCTION: Direct quantification of atherosclerotic plaque volume by three-dimensional 
vascular ultrasound (3DVUS) is more reproducible than 2DUS-based three-dimensional (2D/3D) 
techniques that generate pseudo-3D volumes from summed 2D plaque areas; however, its 
accuracy has not been reported. We aimed to determine 3DVUS accuracy for plaque volume 
measurement with special emphasis on small plaques (a hallmark of early atherosclerosis). 
METHODS: The in vitro study consisted of nine phantoms of different volumes (small and 
medium-large) embedded at variable distances from the surface (superficial vs. >5cm-depth) and 
comparison of 3DVUS data generated using a novel volumetric-linear array method with the real 
phantom volumes. The in vivo study was undertaken in a rabbit model of atherosclerosis in which 
3DVUS and 2D/3D volume measurements were correlated against gold-standard histological 
measurements.  
RESULTS: In the in vitro setting, there was a strong correlation between 3DVUS measures and 
real phantom volume both for small (3.0 to 64.5mm3 size) and medium-large (91.1 to 965.5mm3 
size) phantoms embedded superficially, with intraclass correlation coefficients (ICC) of 0.99 and 
0.98, respectively; conversely, when phantoms were placed at >5cm, the correlation was only 
moderate (ICC=0.67). In the in vivo setting there was strong correlation between 3DVUS-
measured plaque volumes and the histological gold-standard (ICC=0.99 [4.02 to 92.5mm3 size]). 
Conversely, the correlation between 2D/3D values and the histological gold standard (sum of 
plaque areas) was weaker (ICC=0.87 [49 to 520mm2 size]), with large dispersion of the 
differences between measurements in Bland-Altman plots (mean error, 79.2mm2). 
CONCLUSIONS: 3DVUS using the volumetric-linear array method accurately measures plaque 
volumes, including those of small plaques. Measurements are more accurate for superficial 
arterial territories than for deep territories. 
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2D US= two-dimensional ultrasound 
2D/3D= 2D-based three-dimensional ultrasound 
3DVUS= three-dimensional vascular ultrasound 
CT= computed tomography 
CV= cardiovascular 
ICC= intrasclass correlation coefficient 
IFD= inter-frame distance 
IMT= intima-media thickness 
LoA= limit of agreement 




Identification of atherosclerotic lesions is increasingly used to improve cardiovascular (CV) risk 
stratification in asymptomatic populations (1,2). Due to its accessibility and the absence of 
radiation, vascular ultrasound (US) is widely used for early detection of atherosclerosis. For many 
years, risk was estimated from measurements of intima-media thickness (IMT) by two-
dimensional (2D) US; however, the validity of this approach for individual CV risk stratification 
has been questioned (2). 2D US plaque measurements such as plaque thickness or area are more 
accurate predictors of CV events than IMT (3,4), but this method is operator-dependent and shows 
high variability (5). Recent evidence suggests that quantification of 2D-based plaque burden, 
rather than area or thickness, is a better predictor of CV events (6,7), prompting the development 
of new three-dimensional vascular US (3DVUS) methods able to quantify plaque burden with 
more reproducibility and accuracy.  
The most widely-explored “Pseudo-3D” vascular US method for clinical applications is the 
manual “Freehand 2D/3D-like sweep” method for carotid plaques, in which a conventional 2D 
probe is manually moved along the patient’s neck. Using this 2D/3D-like method, our group 
recently showed that the identification and quantification of carotid atherosclerotic plaques results 
in an improvement in risk stratification over traditional equations and coronary calcium score in 
asymptomatic high-risk individuals (8). However, this 2D/3D-like freehand method is technically 
challenging because manual sweep speed is not constant and results are not highly reproducible, 
limiting its use to highly-specialized laboratories (9). In addition, its accuracy for quantifying 
plaque burden has not been established. To allow estimates of plaque volume and improve 
reproducibility, the “mechanical sweep” approach emerged, in which an external device is used 
to move the 2D probe with constant velocity. However, this method is cumbersome and has not 
been taken into clinical practice. To circumvent these technical limitations, a new 3DVUS 
methodology has been developed, based on commercially available advanced volumetric-linear 
array probes (9,10). This modality uses an internally steered array that performs a single-
mechanical sweep to acquire high-resolution 3D volume images from a fixed position. 3DVUS 
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increases the reproducibility of volume quantification for large plaques in the carotid territory (9-
11); however, the accuracy of this technique has not been validated in vivo and data are lacking 
on its utility for measuring plaques of different sizes and in different vascular territories. The 
importance of evaluating early plaques in multiple territories is highlighted by the baseline 
findings of the PESA (Progression of Early Subclinical Atherosclerosis) study, which reveal a 
high incidence of plaques in the femoral territory in a low risk population (12).  
In this study we present the first validation of the accuracy of 3DVUS for real plaque volume 
quantification in vitro and in vivo, with special emphasis on early (small) atherosclerotic plaques 
and on the influence of the depth of the territory explored. 
METHODS 
1. In vitro phantom study 
1.1. Study design 
a) Influence of plaque size on volume quantification 
Calibration standards or "phantoms" that mimic tissue are widely used to establish the accuracy 
and reliability of diagnostic ultrasound techniques (13). We designed nine small-volume 
phantoms, below the 69mm3 threshold for accurate 3D measurement established for previous 
methods (14,15), to establish whether 3DVUS can accurately determine small plaque volumes in 
a controlled laboratory setting. Seven additional phantoms mimicking medium-large plaques 
(≥70mm3) were analyzed to establish whether plaque size influences volume quantification 
accuracy. This phantom set is the largest used to date to validate 3DVUS (9). Phantoms consisted 
of a rigid polyurethane foam “plaque” placed on the wall of a fake artery: a silicon tube with a 
6mm inner diameter and a wall thickness of 0.89mm, similar to the dimensions of a carotid or 
femoral artery (16) (Figure 1A). The real volumes of polyurethane plaques were determined by 
weighing them on a high-precision scale and dividing by the polymer density (1.22mg/mm3; 
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Sikaflex-1A®, Sika-Industry, Baar, Switzerland). The phantoms were embedded superficially in 
2cm-deep agarose blocks to mimic the tissue surrounding arteries (17).  
b) Influence of vessel depth on plaque volume quantification 
To measure the effect of vessel depth on 3D measurement, three new phantoms were prepared 
and embedded in an agarose block at a depth of 3cm, a common depth for carotid and femoral 
arteries. We used small-plaque phantoms in this experiment in order to test the more challenging 
measurement of small volumes. After imaging and analyzing by 3DVUS more agarose was added 
to increase the depth to 5cm, mimicking deeper arteries such as the iliac arteries or abdominal 
aorta, and the phantoms were imaged and analyzed again. 
1.2. In vitro 3DVUS methodology 
The 3DVUS protocol was performed with a Philips iU22 ultrasound system equipped with the 
VL13-5 3D volume-linear array transducer (Philips Health Care, Andover, MA, USA), which 
houses an internal mechanically steered array that provides quantifiable 3D volume data. 
Maintaining a fixed position, the transducer conducts a fan-like continuous automated sweep with 
a constant angular velocity. The transducer operates over a wide frequency range (13 to 5MHz), 
and the inter-frame distance (IFD) is controlled by adjusting the angular sweep length from 10 to 
30 degrees to obtain inter-frame distances between 0.1 mm and 0.3 mm. The length of vessel 
scanned thus depends on the defined angular length. The phantom acquisition protocol consisted 
of a 30 degree sweep. A 30 degree acquisition protocol was selected in order to determine the 
accuracy achieved with the lowest resolution (the largest IFD) of the novel volume-linear array 
probe. The probe was centered on an axial view of the phantom. Depth, focus, and gain were 
adjusted, and automatic scan was initiated. The 3D volumetric image was reviewed and accepted 
only if the phantom was correctly centered on the x, y and z axes (Figure 1B). 
The acquired 3DVUS images were analyzed using the Vascular Plaque Quantification (VPQ) 
feature of QLAB 10.2 (Philips Health Care, Andover, MA, USA). VPQ fits three 3D meshes, one 
for the outer-wall of the vessel, another for the inner-wall and a final one for the plaque boundary. 
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The outer-wall boundary at the level of the plaque and plaque boundary meshes are then used to 
calculate plaque volume as the three-dimensional space between them. This plaque boundary 
contour has the advantage that it can be fitted to calculate the plaque volume alone, excluding 
healthy portions of the surrounding vessel wall (Figure 1C). The 3D dataset is displayed as 
multiple consecutive transverse slices. To analyze atherosclerotic plaques, a semiautomatic 
delineation tool was developed based on a gray-scale threshold procedure. The outer and inner 
vessel borders are manually adjusted using a moldable ellipsoid ROI, and the plaque outline is 
then automatically traced and smoothness and sensitivity of the gray-scale are adjusted to fit the 
plaque boundary (Figure 1C). After delineating the begin frame, end frame and key frames, the 
program automatically extrapolates contours throughout the vessel image. Readers review and 
correct the automatically propagated contours and boundaries, and can manually delineate the 
plaque outline if the automated tool is affected by artifacts, plaque features, or a poor acoustic 
window. For phantom analysis, begin and end frames were set at the phantom edges and one key 
frame was set at the point of maximum phantom thickness. 
2. In vivo validation by histology 
2.1. Study design 
The accuracy of 3DVUS for plaque volume quantification in peripheral atherosclerotic plaques 
was tested in the New Zealand White rabbit model, in which atherosclerosis is induced with the 
angioplasty-balloon aortic endothelial denudation method followed by a cholesterol-rich (0.2%) 
diet for 30 weeks (18,19). The adult rabbit abdominal aorta is similar to human carotids in size 
(≈6mm) and depth (≈2-4cm). Moreover, atherosclerotic plaques generated in this rabbit model 
resemble human early atherosclerotic plaques in size and composition (19). The distance from the 
origin of the left renal artery and the right renal artery were used as internal reference points for 
matching the in vivo US imaging studies with histology. Rabbit abdominal aortas were scanned 
at week 30 by the 2D/3D-like freehand and 3DVUS methods, with focus on the inter-renal 
segments, to detect atherosclerotic plaques at this level and quantify plaque volume. After 
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completion of the imaging studies, aortas were removed, fixed in 10% buffered-formalin, and 
processed for histological analysis. Inter-renal aortic segments were cut into cross-sectional slices 
every 0.2 mm with a section thickness of 4μm, corresponding to the IFD on US plaque images. 
Sections were stained with hematoxylin and eosin, and slides were digitalized. All animal studies 
were performed under the approval of the Institutional Animal Research Committee and carried 
out in compliance with the Guide for the Care and Use of Laboratory Animals. 
2.2. In vivo methodologies for 2D/3D-like and 3DVUS ultrasound 
Rabbits were sedated with ketamine (10 mg/kg IM) and xylazine (2.5 mg/kg IM) and positioned 
supine on the exploration table with the abdomen shaved. For the 2D/3D-like method, a Lio9-15 
2D high-resolution linear array transducer (Philips Health Care, Andover, MA, USA) was used 
to scan the abdominal aorta in cross-section; the transducer was moved manually from the 
proximal to the distal segment of the vessel, including the origin of the left and right renal arteries, 
in about 10 seconds at a constant scan sweep velocity. The acquired images were read with QLAB 
software. Consecutive plaque areas expressed in mm2 from each frame were analyzed and 
summed in the 2D freehand sweep for plaque burden estimation. 
For 3DVUS, the acquisition protocol consisted of a 30 degree sweep, corresponding to a scan 
length of approximately 6cm, with the probe centered on an axial view of the abdominal aorta at 
the origin of the left renal artery (x axis) and parallel to the long-axis of the aorta (y axis). The 
sweep thus included the origin of the left and right renal arteries. Focus, depth, and gain were 
optimized, and the 3D sweep was performed automatically in about 2 seconds. The 3D volumetric 
image was accepted only if the vessel was correctly centered on the 3 dimensional axes and was 
free of any movement artifact (Figure 2A). The acquired 3DVUS images were read according to 
the procedure described for the in vitro experiment, setting the begin and end frames at the 
histologically matched aortic segment edges and with one key frame set at the point of maximum 




2.3. Histological measurements of plaque volume 
Planimetric analysis of histological images was performed using NDP viewer software 
(NDP.view2 Hamamatsu Photonics, UK). In brief, we traced the inner media boundary (yellow), 
the outer or adventitia-media boundary (red), and the plaque border (green) in all images, 
obtaining internal, intermediate, and external areas, respectively (Figure 2C). We calculated the 
following parameters: lumen area was the internal area, plaque area was the difference between 
intermediate and lumen areas, and wall area was the difference between external and lumen areas, 
similar to the slice-by-slice 3DVUS analysis. Datasets of contiguous slices were obtained for each 
plaque specimen, and plaque volume was calculated as the sum of plaque areas multiplied by the 
inter-slice distance. 
3. Statistics 
For the in vitro study, ultrasound phantoms were scanned and analyzed by three sonographers 
experienced in vascular US and blinded to the real volumes. Interobserver reproducibility was 
calculated for plaque volume measurement to estimate the effect of variability on the accuracy of 
plaque volume estimation. Moreover, systematic reading errors were minimized by taking the 
mean of the 3 readers’ measurements, and variation was estimated from the standard deviation 
(SD) of the calculated mean. We conducted a feasibility analysis to determine the ability of the 
semiautomated analysis tool to detect early atherosclerotic plaques and the need for manual 
editing of the plaque contours. Accuracy, agreement and possible observer-induced bias in the 
3DVUS methodology were evaluated by Pearson’s correlation coefficient (r); the mean of the 
relative changes ± 1SD, calculated as the mean of the percentage differences between observed 
volumes relative to real volumes ({observed volume-real volume}/real volume x 100); intraclass 
correlation coefficient (ICC); and Bland-Altman plots. 
For the in vivo histological study, one cardiologist experienced in US imaging of rabbits and 
blinded to the histological measurements scanned and made the offline QLAB reading for the 
2D/3D-like and 3DVUS images. Comparisons were made between the summed plaque areas 
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measured from histological and 2D/3D-like data, as well as between the plaque volume 
measurements from histological and 3DVUS data. Accuracy, agreement, and bias were evaluated 
by r correlation, ICC, and Bland-Altman plots. For ICC, good agreement was defined as >0.70 
and excellent agreement as >0.90. For Bland-Altman plots, the limits of agreement (LoA) lines 
were calculated and plotted, representing the mean±2SD of the inter-measurement difference. 
Statistical analyses were conducted using Stata12 (StataCorp LP, Texas, USA). 
RESULTS 
1. In vitro phantom validation study: accuracy of 3D volume quantification 
a) Influence of plaque size on volume quantification 
The semiautomatic plaque analysis tool successfully discriminated all phantom plaque outlines. 
The mean real volume of small phantom plaques was 22±19.7mm3 (range 3.03-64.5mm3) and the 
3DVUS measured volume was 24±18.7mm3 (range 3.9-60.8mm3). For medium-large phantom 
plaques, mean real volume was 351.6±306mm3 (range 91.1-965.5mm3) and the 3DVUS volume 
was 398.3±323.4mm3 (range 121.3-1037.2mm3). Accuracy of volume quantification was 
excellent for small phantom plaques (ICC=0.99; r=0.992 p<0.001) and medium-large phantoms 
(ICC=0.98; r=0.999 p<0.001) (Figure S1 A and B). Bland-Altman plots confirmed this good 
agreement. 3DVUS slightly overestimated the volumes of larger plaques (Figure 3B). The mean 
measurement error was 1.3mm3 (LoA -5.9-8.4mm3) for small plaques (mean of the relative 
changes 19±12%) and 46.7mm3 (LoA 87.8-5.6mm3) for medium-large plaques (mean of the 
relative changes 14±10%). 
There was good reproducibility of plaque volume measurement: ICC = 0.998 (IC95% 0.994-
0.999) for observers 1 and 2, ICC = 0.996 (IC95% 0.982-0.992) for observers 1 and 3, and ICC 
= 0.997 (IC95% 0.986-0.999) for observers 2 and 3. 
b) Influence of vessel depth on small plaque volume quantification 
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The mean real volume of the set of phantom plaques examined in the vessel depth experiment 
was 26.9±25.3mm3 (range 6.5-55.2mm3). 3DVUS-measured volume for superficially embedded 
phantoms was 27.9±26.8mm3 (range 6.4-57.9mm3), showing excellent accuracy (ICC=0.99; 
r=0.997 p<0.001) (Figure S1C). A Bland-Altman plot confirmed this good agreement (Figure 
3C). In contrast, the 3DVUS-measured volume for deeply embedded phantoms was 
47.8±41.9mm3 (range 11.8-93.8mm3), which deviated significantly from the real volume (ICC = 
0.67) (Figure S1D). A Bland-Altman plot showed large dispersion of the differences between 
observations, with mean = 20.828mm3 and LoA -12.659 to 54.316mm3 (Figure 3D). 
2. In vivo validation by histology 
The in vivo US studies used to define plaques induced at the inter-renal aortic segment detected 
nine atherosclerotic plaques, all of which were validated by histology. The 3D semiautomatic 
plaque analysis tool detected all plaques. For most plaques, the semiautomatic plaque outline 
required slight manual editing for perfect alignment with the plaque boundaries. The main cause 
of semiautomatic tool failure was the presence of low-echogenic plaques typical of early 
atherosclerotic disease. The mean histological volume of the nine plaques was 34.2±29.04mm3 
(range 3.9 to 96 mm3), and the mean 3DVUS-measured plaque volume was 33.4±27.99mm3 
(range 4.02 to 92.5mm3). As judged by comparison to the histological volumes, the accuracy of 
plaque volume quantification by 3DVUS was excellent (ICC=0.99; r=0.998 p<0.001), with 
Bland-Altman plots showing very small dispersion of the differences, without systematic bias 
(Figure 4 A and C).  
When evaluated by the 2D/3D-like method, the mean sum of plaque areas was 203.2±158.1mm2 
(rage 49 to 520mm2), while in the histological analysis, the mean sum of plaque areas was 
124±95.5mm2 (rage 19.1 to 316mm2). This results in a weaker correlation with the sum calculated 
by histological analysis (ICC =0.86), with Bland-Altman plots showing large dispersion of the 
differences (mean error of 79.212 mm2 and LoA -55.883 to 214.307mm2), together with a 
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systematic increase in the overestimation of plaque area with increasing plaque size (Figure 4 B 
and D). 
DISCUSSION:  
Accurate quantification of atherosclerotic burden requires a reliable method for measuring plaque 
volume. In the present study, we show that 3DVUS using a novel volume-linear array probe 
accurately quantifies plaque volume regardless of plaque size. Notably, 3DVUS precisely 
quantified small plaques, a hallmark of early atherosclerosis, when risk stratification is of greatest 
value. However, the accuracy of 3DVUS for plaque volume quantification is limited for deep 
vessels, suggesting that this technique is better suited for superficial vessels (i.e. carotids and 
femorals).  
Previous studies have evaluated the accuracy of 3DVUS for plaque volume quantification using 
in vitro phantoms resembling large plaques (9,11,20). Our study is the first to comprehensively 
evaluate the in vitro accuracy of this novel method across a range of phantom volumes, including 
those resembling small plaques. Although estimated and real plaque volumes correlate closely, 
the Bland-Altman volume graphs show a slight overestimation for larger phantom plaques with 
the 3DVUS method. Despite this small systematic error, there is no proportional bias, and all 
differences fall in a narrow window within the limits of agreement, supporting the overall good 
performance of 3DVUS for plaque volume estimation. Phantoms were analyzed with the 
semiautomatic tool, which fits contours to the plaque boundary using a gray-scale threshold 
algorithm. Although phantoms are calibration imagines with well-defined contours, the 
semiautomatic fit is imperfect, and minute errors can lead to slight overestimation of plaque 
volume. These errors can be detected by experienced sonographers, and overestimation could thus 
be reduced by editing the contours manually. In the in vivo study, we used semiautomatic analysis 
with manual corrections when needed, and Bland-Altman plots showed no estimation errors and 
volume measurement proved to be highly accurate. The effect of the error due to semiautomatic 
fitting is very small and unlikely to be clinically significant; moreover, automatic analysis 
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improves the reproducibility of volume measurements. Another way to improve semiautomatic 
tool performance would be to use a smaller interframe distance in 3DVUS acquisition (20 or 10 
degree sweep), thereby increasing plaque image resolution. 
The present study is also the first in vivo validation of this method, showing that 3DVUS-
quantified plaque volume correlates closely with plaque volume assessed by the histological gold 
standard. Moreover, 3DVUS performed better than the 2D/3D-like freehand method, a pseudo-
3D method used to indirectly estimate plaque volume (6,8). A key factor for accurate 3D volume 
acquisition by 3DVUS is the sweep motion along the third dimension (z axis) of the image, which 
determines the IFD and thus the image resolution. So far, three approaches have been developed 
for acquiring 3D images of vessels (Figure 5). The 2D/3D-like freehand method resulted in a 
variable IFD, and the resolution of the old “mechanical sweep” methods (from 0.5 to 5mm IFD) 
remains limited (21). Moreover, these methods are cumbersome and difficult to standardize and 
implement in clinical practice across centers. In the 3DVUS method, an internally steered linear 
array makes a single mechanical sweep to acquire high-resolution 3D volume images (0.1 to 
0.3mm IFD) from a fixed position, simplifying image acquisition and improving resolution. The 
reproducibility of volume measurements with these three techniques has been determined as a 
surrogate of their accuracy in previous studies (22). Although constant sweep velocity improves 
measurement reproducibility (9), accurate determination of plaque volume is also determined by 
the IFD (21). Indeterminate or widely separated IFD likely underlie the poor axial resolution of 
small plaques (< 70 mm3) reported for the 2D/3D-like freehand method and mechanically steered 
external 2D probes, limiting their use in early atherosclerosis (14,15,20). Despite its limitations, 
we used the 2D/3D-like freehand method for comparison with 3DVUS because it is the most 
widely used pseudo-3D US method for estimating plaque burden (6,8). In the present report, the 
lower accuracy of the 2D/3D-like freehand method compared with the histological gold standard 
is thus consistent with the previous studies of reproducibility. In contrast, the 3DVUS method 
overcomes these limitations both in vitro and in vivo, and results in a good correlation with the 
histological gold-standard.  
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The accuracy of a biomarker such as plaque volume is an important determinant of the reliability 
of new clinical strategies. A precise knowledge of biomarker accuracy is important for ensuring 
generalizability of thresholds and cut-off values between centers, achieving precise evaluation of 
disease progression/regression, and ensuring reliable follow-up data. Our results establish 
3DVUS as the first 3D method that accurately estimates plaque burden, particularly in relation to 
small plaques. This method is therefore especially suited to the evaluation of subclinical disease. 
3DVUS is currently being used in the PESA trial to study the determinants of plaque burden 
presence and progression in the carotid and femoral arteries of more than 4000 apparently healthy 
middle-aged individuals (23). Our data also show that the depth of the territory being explored 
has an impact on the accuracy of 3DVUS for plaque volume quantification. Interestingly, the 
most frequently affected vascular territory in the baseline PESA study was the femoral, followed 
by the carotids. Both these territories are superficial and thus not affected by the limitations of 
deep vessels described here. In contrast, our results question the reliability of the 3DVUS method 
for the evaluation of large arterial territories below a depth of 5cm. The 3D volume-linear array 
probe has a broad operating frequency in 2D mode that in principle should permit scanning of 
superficial and deep structures; however, the 3D image is constructed from a series of 2D fan-like 
images, and the fan-form of the sweeping US beam means that IFD increases slightly with 
increasing depth (Figure S2). This effect has been reported to degrade resolution in the elevational 
plane (y axis) (24) and is a plausible source of the observed error in small-plaque quantification 
at higher penetration depths in our experiment. The fact that most early atherosclerotic plaques in 
the PESA cohort were found in superficial vascular territories adds value to the use of 3DVUS as 
a reliable technique for plaque volume quantification, and eventually risk re-stratification, in low-
to-mid risk populations.  
One limitation of this study is the relatively small number of phantoms designed for the in vitro 
experiment, particularly the 3-phantom experiment assessing the effect of depth. The phantom 
experiments also did not assess the effect of plaque shape on the accuracy of volume 
measurement. However, these limitations do not affect the in vivo experiment, in which we 
16 
 
evaluated volume measurement accuracy for real plaques with different morphologies and, more 
importantly, different plaque composition, including varying degrees of calcification. The in vivo 
model also allowed the evaluation of atherosclerotic plaques under physiological conditions of 
vessel pulsatility, and accuracy was comparable to the in vitro model. The use of histology as the 
gold standard for plaque volume estimation has been linked to fixation and processing problems. 
Histological assessment can be affected by artifacts and shrinkage, but these in fact depend on the 
degree of atherosclerosis in the processed arterial segment. Siegel et al (25) first showed that in 
vessels with mild atherosclerotic narrowing, standard tissue processing results in a non-significant 
change in absolute measurements of plaque area. More recent studies reported very small changes, 
of around 5%, when using modern histological techniques. This evidence supports the reliability 
of our results, and although histological shrinkage cannot be excluded, any effect would similarly 
influence the precision of the 3DVUS and 2D/3D-like methods.   
CONCLUSIONS: 
3DVUS with the novel volumetric-linear array method gives highly accurate measures of plaque 
volume regardless of plaque size. The accuracy is very high for plaques present in superficial 
territories and lower for those in deeper territories (>5cm). This technique is significantly more 
accurate than the currently used 2D/3D-like freehand method. 3DVUS has the potential to 
improve risk stratification based on atherosclerotic plaque burden. 
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FIGURE TITLES AND LEGENDS 
Figure 1. Small plaque phantom 
(A) An ultrasound phantom before embedding in agarose. The polyurethane “plaque” is marked 
by an arrow. (B) 3D automatic sweep acquisition of a small phantom plaque. Panels 1, 2 and 3 
show the X, Y and Z axis views of the phantom. (C) Semiautomatic delineation of consecutive 










Figure 2. Atherosclerotic plaque quantification on 3DVUS matched with histological 
findings 
(A) 3D automatic sweep acquisition of an atherosclerotic plaque located at the origin of the left 
renal artery in the abdominal aorta of a New Zealand rabbit. (B) Semiautomatic delineation of an 
axial view of the atherosclerotic plaque with VPQ software and (C) a matched histological cross 
section of the plaque. Red and yellow contours delimitate outer and inner vessel borders. The 
green contour delimits the plaque border, excluding healthy portions of the surrounding vessel 






Figure 3. In vitro accuracy of volume quantification using 3DVUS 
Bland-Altman plots of volume measurement in small and medium-large plaque phantoms (A and 
B). Bland-Altman plots of volume measurement in small plaque phantoms placed at different 





Figure 4. In vivo accuracy of 3DVUS and the 2D/3D-like freehand method 
Accuracy of 3DVUS volume measurement compared with histology (A and C). Accuracy of 













Figure S1. In vitro accuracy of volume quantification using 3DVUS 
Correlation of volume measurement in small and medium-large plaque phantoms with the “real” 
volume (calculated from mass and density). Values are means of the readings by three observers. 
Vertical error bars represent ± 1 standard deviation. (A and B) Correlation of volume 
measurement for different plaque sizes. (C and D) Correlation of volume measurement in small 
phantoms placed at different depths, showing good results for superficial phantoms but large 







Figure S2. Scheme illustrating the loss of resolution with depth (y axis) due to the fan-like 
movement the 3DVUS volume-linear array probe 
 
 
